Related Experiment Video
Updated: Oct 30, 2025
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Therapy Prospects for Mitochondrial DNA Maintenance Disorders
Javier Ramón1,2, Ferran Vila-Julià1,2, David Molina-Granada1,2
1Research Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Abstract:
Mitochondrial DNA depletion and multiple deletions syndromes (MDDS) constitute a group of mitochondrial diseases defined by dysfunctional mitochondrial DNA (mtDNA) replication and maintenance. As is the case for many other mitochondrial diseases, the options for the treatment of these disorders are rather limited today. Some aggressive treatments such as liver transplantation or allogeneic stem cell transplantation are among the few available options for patients with some forms of MDDS. However, in recent years, significant advances in our knowledge of the biochemical pathomechanisms accounting for dysfunctional mtDNA replication have been achieved, which has opened new prospects for the treatment of these often fatal diseases. Current strategies under investigation to treat MDDS range from small molecule substrate enhancement approaches to more complex treatments, such as lentiviral or adenoassociated vector-mediated gene therapy. Some of these experimental therapies have already reached the clinical phase with very promising results, however, they are hampered by the fact that these are all rare disorders and so the patient recruitment potential for clinical trials is very limited.
Insights
Mitochondrial DNA depletion and multiple deletions syndromes (MDDS) are severe genetic disorders. New treatments like gene therapy show promise, but rare disease patient recruitment for clinical trials remains a challenge.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Mitochondrial DNA depletion and multiple deletions syndromes (MDDS) are debilitating mitochondrial diseases.
- Dysfunctional mitochondrial DNA (mtDNA) replication and maintenance characterize these rare genetic disorders.
- Current treatment options for MDDS are limited, with aggressive interventions like transplantation being rare alternatives.
Purpose of the Study:
- To explore novel therapeutic strategies for MDDS, addressing the limited treatment landscape.
- To highlight recent advancements in understanding the biochemical basis of mtDNA replication defects.
- To review emerging treatments and their potential impact on these fatal diseases.
Main Methods:
- Investigating small molecule substrate enhancement approaches for MDDS treatment.
- Evaluating gene therapy vectors, including lentiviral and adeno-associated viral (AAV) vectors.
- Analyzing the clinical progress and challenges of experimental MDDS therapies.
Main Results:
- Significant progress has been made in understanding the pathomechanisms of mtDNA replication.
- Experimental therapies, including gene therapy, have shown promising early clinical results.
- The rarity of MDDS poses significant challenges for patient recruitment in clinical trials.
Conclusions:
- Advances in understanding mtDNA replication offer new therapeutic avenues for MDDS.
- Gene therapy and other novel approaches represent promising, albeit experimental, treatments.
- Overcoming patient recruitment limitations is crucial for advancing clinical trials in rare mitochondrial diseases.
More Related Videos
07:24Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
Published on: November 23, 2011
Related Concept Videos
02:59Animal Mitochondrial Genetics
01:39Mitochondrial Precursor Proteins
Most of the mitochondrial...
01:45Mitochondrial Membranes
01:37Mitochondria
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:39Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...